Literature DB >> 31619473

Diverse cardiopulmonary diseases are associated with distinct xenon magnetic resonance imaging signatures.

Ziyi Wang1,2,3, Elianna A Bier1,2,3, Aparna Swaminathan4, Kishan Parikh4, John Nouls5, Mu He2,6, Joseph G Mammarappallil5, Sheng Luo7, Bastiaan Driehuys1,2,5, Sudarshan Rajagopal8.   

Abstract

BACKGROUND: As an increasing number of patients exhibit concomitant cardiac and pulmonary disease, limitations of standard diagnostic criteria are more frequently encountered. Here, we apply noninvasive 129Xe magnetic resonance imaging (MRI) and spectroscopy to identify patterns of regional gas transfer impairment and haemodynamics that are uniquely associated with chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), left heart failure (LHF) and pulmonary arterial hypertension (PAH).
METHODS: Healthy volunteers (n=23) and patients with COPD (n=8), IPF (n=12), LHF (n=6) and PAH (n=10) underwent 129Xe gas transfer imaging and dynamic spectroscopy. For each patient, three-dimensional maps were generated to depict ventilation, barrier uptake (129Xe dissolved in interstitial tissue) and red blood cell (RBC) transfer (129Xe dissolved in RBCs). Dynamic 129Xe spectroscopy was used to quantify cardiogenic oscillations in the RBC signal amplitude and frequency shift.
RESULTS: Compared with healthy volunteers, all patient groups exhibited decreased ventilation and RBC transfer (both p≤0.01). Patients with COPD demonstrated more ventilation and barrier defects compared with all other groups (both p≤0.02). In contrast, IPF patients demonstrated elevated barrier uptake compared with all other groups (p≤0.007), and increased RBC amplitude and shift oscillations compared with healthy volunteers (p=0.007 and p≤0.01, respectively). Patients with COPD and PAH both exhibited decreased RBC amplitude oscillations (p=0.02 and p=0.005, respectively) compared with healthy volunteers. LHF was distinguishable from PAH by enhanced RBC amplitude oscillations (p=0.01).
CONCLUSION: COPD, IPF, LHF and PAH each exhibit unique 129Xe MRI and dynamic spectroscopy signatures. These metrics may help with diagnostic challenges in cardiopulmonary disease and increase understanding of regional lung function and haemodynamics at the alveolar-capillary level.
Copyright ©ERS 2019.

Entities:  

Year:  2019        PMID: 31619473     DOI: 10.1183/13993003.00831-2019

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  12 in total

1.  Mapping cardiopulmonary dynamics within the microvasculature of the lungs using dissolved 129Xe MRI.

Authors:  Peter J Niedbalski; Elianna A Bier; Ziyi Wang; Matthew M Willmering; Bastiaan Driehuys; Zackary I Cleveland
Journal:  J Appl Physiol (1985)       Date:  2020-06-18

2.  Utilizing flip angle/TR equivalence to reduce breath hold duration in hyperpolarized 129 Xe 1-point Dixon gas exchange imaging.

Authors:  Peter J Niedbalski; Junlan Lu; Chase S Hall; Mario Castro; John P Mugler; Yun M Shim; Bastiaan Driehuys
Journal:  Magn Reson Med       Date:  2021-10-13       Impact factor: 4.668

Review 3.  Novel Approaches to Imaging the Pulmonary Vasculature and Right Heart.

Authors:  Fawaz Alenezi; Taylor A Covington; Monica Mukherjee; Stephen C Mathai; Paul B Yu; Sudarshan Rajagopal
Journal:  Circ Res       Date:  2022-04-28       Impact factor: 23.213

4.  Bias field correction in hyperpolarized 129 Xe ventilation MRI using templates derived by RF-depolarization mapping.

Authors:  Junlan Lu; Ziyi Wang; Elianna Bier; Suphachart Leewiwatwong; David Mummy; Bastiaan Driehuys
Journal:  Magn Reson Med       Date:  2022-05-04       Impact factor: 3.737

5.  Using hyperpolarized 129Xe gas-exchange MRI to model the regional airspace, membrane, and capillary contributions to diffusing capacity.

Authors:  Ziyi Wang; Leith Rankine; Elianna A Bier; David Mummy; Junlan Lu; Alex Church; Robert M Tighe; Aparna Swaminathan; Yuh-Chin T Huang; Loretta G Que; Joseph G Mammarappallil; Sudarshan Rajagopal; Bastiaan Driehuys
Journal:  J Appl Physiol (1985)       Date:  2021-03-18

Review 6.  Imaging Inflammation - From Whole Body Imaging to Cellular Resolution.

Authors:  Tuula Peñate Medina; Jan Philip Kolb; Gereon Hüttmann; Robert Huber; Oula Peñate Medina; Linh Ha; Patricia Ulloa; Naomi Larsen; Arianna Ferrari; Magdalena Rafecas; Mark Ellrichmann; Mariya S Pravdivtseva; Mariia Anikeeva; Jana Humbert; Marcus Both; Jennifer E Hundt; Jan-Bernd Hövener
Journal:  Front Immunol       Date:  2021-06-24       Impact factor: 7.561

7.  Pulmonary Arterial Hypertension: Diagnosis, Treatment, and Novel Advances.

Authors:  Bradley A Maron; Steven H Abman; C Greg Elliott; Robert P Frantz; Rachel K Hopper; Evelyn M Horn; Mark R Nicolls; Oksana A Shlobin; Sanjiv J Shah; Gabor Kovacs; Horst Olschewski; Erika B Rosenzweig
Journal:  Am J Respir Crit Care Med       Date:  2021-06-15       Impact factor: 30.528

Review 8.  In vivo methods and applications of xenon-129 magnetic resonance.

Authors:  Helen Marshall; Neil J Stewart; Ho-Fung Chan; Madhwesha Rao; Graham Norquay; Jim M Wild
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2020-12-09       Impact factor: 9.795

9.  Hyperpolarized 129Xe MRI and Spectroscopy of Gas-Exchange Abnormalities in Nonspecific Interstitial Pneumonia.

Authors:  David G Mummy; Elianna A Bier; Ziyi Wang; Jennifer Korzekwinski; Lake Morrison; Christina Barkauskas; H Page McAdams; Robert M Tighe; Bastiaan Driehuys; Joseph G Mammarappallil
Journal:  Radiology       Date:  2021-07-27       Impact factor: 29.146

10.  Role of biomarkers in evaluation, treatment and clinical studies of pulmonary arterial hypertension.

Authors:  Anna Hemnes; Alexander M K Rothman; Andrew J Swift; Lawrence S Zisman
Journal:  Pulm Circ       Date:  2020-11-18       Impact factor: 2.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.